Publikasi Scopus FKUI Tahun 2010 s/d 2020 (data Per 3 Februari 2021)

Cahyanur R., Setyawan W., Sudrajat D.G., Setyowati S., Purnamasari D., Soewondo P.
37066991400;54893032800;54893136100;54893136300;36519537700;23475336100;
Diagnosis and management of acromegaly: giant invasive adenoma.
2011
Acta medica Indonesiana
43
2
122
128
3
Department of Internal Medicine, Faculty of Medicine, University of Indonesia-Cipto Mangunkusumo Hospital. Jl. Diponegoro no. 71, Jakarta, Indonesia
Cahyanur, R., Department of Internal Medicine, Faculty of Medicine, University of Indonesia-Cipto Mangunkusumo Hospital. Jl. Diponegoro no. 71, Jakarta, Indonesia; Setyawan, W.; Sudrajat, D.G.; Setyowati, S.; Purnamasari, D.; Soewondo, P.
Acromegaly is a rare disorder caused by excessive growth hormone. Majority of acromegaly are due to pituitary adenoma. It is estimated that 5% of pituitary adenoma become invasive and may grow to gigantic sizes (>4 cm in diameter). We would like to describe a man with giant invasive adenoma. We describe the case of 52-year-old man with acromegaly. The patient was presented to medical care because of hemichorea. He also had visual field defect, uncontrolled diabetes, and dyslipidemia. Hormonal profile showed increment of GH 2-hour after a standard 75-g oral glucose load and of high IGF-1 level with low level of FSH and LH. The next was performed by pituitary imaging. Magnetic resonance imaging showed a macroadenoma with diameter 2.3x3.5x6.6 cm3 that fills the sella tursica, and enlarges into suprasella, genu of corpus collosum, and invades third ventricle. This report describes a rare case of acromegalic patient with giant invasive adenoma. This could be a demonstrative case and lesson for diagnosis and manage acromegalic patient.
antidiabetic agent; bromocriptine; follitropin; growth hormone; hormone antagonist; luteinizing hormone; metformin; somatomedin C; acromegaly; article; case report; human; hypophysis tumor; male; middle aged; nuclear magnetic resonance imaging; pathology; Acromegaly; Bromocriptine; Follicle Stimulating Hormone; Growth Hormone; Hormone Antagonists; Humans; Hypoglycemic Agents; Insulin-Like Growth Factor I; Luteinizing Hormone; Magnetic Resonance Imaging; Male; Metformin; Middle Aged; Pituitary Neoplasms
01259326
21785175
Article
Q3

Unit Riset FKUI/Medical Research Unit
Gedung IMERI Tower Riset lt. 9, Jl. Salemba Raya No. 6, Jakarta Pusat, 10430
Telp. : +62 21 29189160 (ext. 201912)
E-mail : manajer.riset.fkui1@gmail.com

© {2022} Riset & Pengabdian Masyarakat. All Rights Reserved.